Showing results (2111-2120 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccinationSimon Voelkl, Tamson V Moore, Michael Rehli, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2008
Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2Kerrington R Molhoek, Chantel C McSkimming, Walter C Olson, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2008
Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentaryGerald J Mizejewski
Cancer Immunology, Immunotherapy : CII|January 28, 2009
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Anti-cancer activity and mechanistic features of a NK cell activating moleculeHyung-Ran Kim, Kyoung-Ho Lee, Su Jung Park, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2009
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenograftsRobert T O'Donnell, Yunpeng Ma, Hayes C McKnight, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2009
BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donorsSylvie Rusakiewicz, Alejandro Madrigal, Paul Travers, et al.
Cancer Immunology, Immunotherapy : CII|July 25, 2009
Comparative proteomical and metalloproteomical analyses of human plasma from patients with laryngeal cancerClarissa P C Gomes, Mirna S Freire, Bruno R B Pires, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2009
Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibilityMarie Lipoldová, Helena Havelková, Jana Badalova, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2009
A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignanciesPina M Cardarelli, Chetana Rao-Naik, Sharline Chen, et al.
Pageof 652